VC  RimLight

http://www.rimlightllc.com





     Office Locations:

736 N. Western Ave., Ste. 325
Lake Forest, IL 60045
Phone: 847-234-5113

 

Stages:

  • Early


 

Industries:

  • Communications & Networking
  • Information Technology

  •  

    Description:

    RimLight, LLC is a privately held, actively managed investment fund that applies experience and specialized investment expertise across a range of public and private investment strategies. Christopher J. Oates is currently the Managing Director of RimLight, and is responsible for all investment and private placement activities. Prior to the formation of the RimLight, LLC fund, Oates held senior level strategic planning, finance, and business development positions in Ortronics, Inc., and Brightpoint, Inc. (NASDAQ: CELL).



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Christopher J. Oates Managing Director

     

    Portfolio companies include:

     

    Recent News: